Barbara Pratscher

SNPase-ARMS qPCR: Ultrasensitive Mutation-Based Detection of Cell-Free Tumor DNA in Melanoma Patients.

Potential of a BPV1 L1 VLP vaccine to prevent BPV1- or BPV2-induced pseudo-sarcoid formation and safety and immunogenicity of EcPV2 L1 VLPs in horse.

Canine oral primary melanoma cells exhibit shift to mesenchymal phenotype and phagocytic behaviour.

Companion Animals as Models for Inhibition of STAT3 and STAT5.

Betulinic acid shows anticancer activity against equine melanoma cells and permeates isolated equine skin in vitro.

Generation of Differentiating and Long-Living Intestinal Organoids Reflecting the Cellular Diversity of Canine Intestine.

A Recurrent Driver Mutation in Feline Alimentary T Cell Lymphoma.

An Equine Model for Vaccination against a Hepacivirus: Insights into Host Responses to E2 Recombinant Protein Vaccination and Subsequent Equine Hepacivirus Inoculation.

Bevacizumab Efficiently Inhibits VEGF-Associated Cellular Processes in Equine Umbilical Vein Endothelial Cells: An In Vitro Characterization.

Traces of Canine Inflammatory Bowel Disease Reflected by Intestinal Organoids.

Cross-Species Comparison of the Pan-RAF Inhibitor LY3009120's Anti-Tumor Effects in Equine, Canine, and Human Malignant Melanoma Cell Lines.

A matter of differentiation: equine enteroids as a model for the in vivo intestinal epithelium.

Deregulation of Metalloproteinase Expression in Gray Horse Melanoma Ex Vivo and In Vitro.

Isolation-protocol, characterization, and performance of equine umbilical vein endothelial cells.